Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Pharmacology|February 9, 2020
Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot studyHaruhiko Yamazaki, Tomoyuki Yokose, Hiroyuki Hayashi, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2018
Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancerHaruhiko Yamazaki, Tomoyuki Yokose, Hiroyuki Hayashi, et al.
Case Reports in Surgery|December 12, 2018
A Large Substernal Goiter that Extended to Both Sides of the ThoraxHirotaka Nakayama, Motohiko Goda, Kaori Kohagura, et al.
Frontiers in Pediatrics|March 8, 2024
Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimusKonomi Shimoda, Hiroyuki Iwasaki, Yoko Mizuno, et al.
Case Reports in Endocrinology|May 26, 2018
A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung MetastasisHaruhiko Yamazaki, Hiroyuki Iwasaki, Toshinari Yamashita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 2, 2017
[Efficacy and Safety of Lenvatinib for Unresectable Anaplastic Thyroid Cancer]Haruhiko Yamazaki, Satoru Shimizu, Hiroyuki Iwasaki, et al.
In Vivo (Athens, Greece)|November 6, 2017
Potential Risk Factors for Nivolumab-induced Thyroid DysfunctionHaruhiko Yamazaki, Hiroyuki Iwasaki, Toshinari Yamashita, et al.
Scientific Reports|February 22, 2023
Estimability study on the age of toddlers' gait development based on gait parametersChisa Tsuyuki, Haruna Hiraga, Motoki Sudo, et al.
Pageof 7